William A Kennedy, MD
Urology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kennedy’s office at (650) 498-7200 to ask if they take your plan before you enroll.
California Medical Board record
Licence G83789 · Current
Licensed to practise in California · since 1997 · expires 2027-04-30 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$67,016 in 2024
Medicaid paid $67,016 for 597 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 289 | $35,813 |
| New patient visit (30+ min) | 202 | $22,754 |
| Short return visit (20+ min) | 94 | $6,462 |
| New patient visit (45+ min) | 12 | $1,987 |
| 2024 | 597 | 4 | 42 | $67,016 |
| 2023 | 838 | 4 | 38 | $73,384 |
| 2022 | 654 | 4 | 29 | $53,286 |
| 2021 | 653 | 4 | 26 | $53,013 |
| 2020 | 460 | 3 | 49 | $25,716 |
| 2019 | 604 | 3 | 38 | $38,122 |
| 2018 | 350 | 3 | 33 | $16,136 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 325 | $30,277 |
| New patient visit (30+ min) | 301 | $28,146 |
| Short return visit (20+ min) | 160 | $9,064 |
| New patient visit (45+ min) | 52 | $5,897 |
2022
| Return visit (30+ min) | 271 | $24,188 |
| New patient visit (30+ min) | 186 | $16,954 |
| Short return visit (20+ min) | 183 | $10,694 |
| Long return visit (40+ min) | 14 | $1,451 |
2021
| Return visit (30+ min) | 227 | $20,429 |
| Short return visit (20+ min) | 232 | $13,364 |
| New patient visit (30+ min) | 120 | $10,904 |
| New patient visit (45+ min) | 74 | $8,316 |
2020
| Short return visit (20+ min) | 357 | $17,679 |
| New patient visit (30+ min) | 86 | $7,043 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 17 | $994 |
2019
| New patient visit (30+ min) | 201 | $17,547 |
| Short return visit (20+ min) | 347 | $16,001 |
| Return visit (30+ min) | 56 | $4,574 |
2018
| Short return visit (20+ min) | 275 | $12,951 |
| Short return visit | 60 | $1,961 |
| New patient visit (30+ min) | 15 | $1,224 |
Money from drug and device companies
$18 in 2025
A payment is not proof that care is biased.
| Ambu | None | $18 | 1 payment
|
See the published payment
| Ambu | Meals · 2025-01-27 | None | $18 |
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Astellas Pharma Global Development · A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed By A Fixed Dose Observation Period To Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-Release Microgranula-Based Suspension in Children From 6 Months To Less Than 3 Years of Age With Neurogenic Detrusor Overactivity · 2025 | Their institution | $23,423 |
| Astellas Pharma Global Development · A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed By A Fixed Dose Observation Period To Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-Release Microgranula-Based Suspension in Children From 6 Months To Less Than 3 Years of Age With Neurogenic Detrusor Overactivity · 2024 | Their institution | $5,414 |
| Astellas Pharma Global Development · Open-Label Phase 3 Study With Mirabegron in Children From 3 To Less Than 18 Years of Age With Neurogenic Detrusor Overactivity · 2020 | Their institution | $3,843 |
Professional record
- NPI
- 1881734655
- Licence
- CA G83789California G83789: Current · expires 2027-04-30
- Trained
- Tufts University School of Medicine, 1989
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2088P0231X (2088P0231X)
- Mailing address
- 300 Pasteur Dr, Dept of Urology Rm S-287, Stanford, CA, 94305
- NPI first listed
- 2007-02-08
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.